AI-Assisted Written Information in Symptomatic Hemorrhoidal Disease
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSanliurfa Education and Research Hospital
About this trial
This single-center, prospective, parallel-group, 1:1 randomized controlled trial compares standardized verbal counseling with AI-assisted written patient information in adults with symptomatic hemorrhoidal disease receiving initial conservative/medical treatment. The primary objective is to determine whether AI-assisted written information improves complete treatment adherence at day 14. Secondary objectives include quality-of-life change, Patient Global Impression of Change, time to symptom improvement, change in pain/discomfort scores, change in bleeding, swelling, itching, and soiling symptoms, and unplanned repeat healthcare visits.
Eligibility criteria
Qualifiers
Age 18 years or older
Diagnosis of symptomatic hemorrhoidal disease in the outpatient clinic
Conservative/medical treatment planned at first evaluation
Ability to read and understand Turkish
Disqualifiers
Planned office procedure or surgery
Emergency conditions such as thrombosed external hemorrhoid, strangulation, or massive bleeding
Concomitant anal fissure, anal fistula, perianal abscess, inflammatory bowel disease, or suspicion of anal/colorectal malignancy
History of hemorrhoidal intervention or surgery within the last 3 months
Trial design
Treatments tested in this trial
- AI-assisted written patient information
- Standardized verbal counseling
Treatment groups
220 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov